Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Geron Corp. -- Ignore unavailable to you. Want to Upgrade?

To: nohalo who wrote (2252)	1/24/2000 9:07:00 AM
From: gmccon	Read Replies (1) \| Respond to of 3576

If he's short, he's in big trouble this morning.

To: nohalo who wrote (2252)	1/24/2000 9:40:00 AM
From: ahhaha	Respond to of 3576

I have been caught long and am selling my shares. This game is too rich for me. You can have my piece of pie in the sky.

To: nohalo who wrote (2252)	1/24/2000 10:02:00 PM
From: George Leeper	Respond to of 3576

DA, Thanx for the back up of questioning of Dr Ah. I questioned his logic in the uptick/downtick count. I don,t have access to level II data but when a stock is up almost 100% in one day, I don't think the downticks really count for much. George Leeper

To: nohalo who wrote (2252)	1/27/2000 10:04:00 PM
From: Can Do Stocks 2	Read Replies (1) \| Respond to of 3576

GERN the most undervalued stock on the market today. IMO Forget that there are only 17 million shares in the co. I advise anyone who is shorting this stock to do a little more homework on the co. and what they are doing. If you get a chance to visit the co or to talk to the people in the know, this co is already testing on human cells for their "reverse" or antiaging products. And they work. Plain and simple, no games...smoke or mirrors. This is a Trillion dollar market and GERN is after the patn. on it all before they let it out. Yes,I said Trillion $ dollar world wide market. What would you pay to live to be 120 years old and be as active as a 60 year old ? This is not a guess ... Ck out their lab tests on human cell degeneration and revitalization. Now this is only one aspect of their research. Geron has 27 issued patents and over 150 pending patent applications covering telomerase composition of matter, methods for screening for molecules that modulate telomerase activity, telomerase modulators and the use of telomerase modulators for the treatment of disease, including cancer and degenerative diseases. Let this co. get those patents and the party is over. The most sought after treatments of all time are on the table to license to Pharmacia & Upjohn or any other co. that has the cash. This co only shows the tip of the iceberg as to what they already have done. So, to sum it all up ... be short when they PR the patents and what they really do and you can kiss you $$$ goodbye. They will stop trading and when they open it up your lunch will be gone as well as all your acct and all your other assets, to cover your call. Good luck to all the longs...this is only the start of a ride to remember.